Reducing Drug Prices for Seniors Act | ChamberLight
Bills · HR 1244
IN COMMITTEE· 119TH CONGRESS
House BillHR 1244MedicareHealth care costs and insurance
Reducing Drug Prices for Seniors Act
INTRO FEB 12· LAST ACTION FEB 12
READING
3MIN
COSPONSORS
2BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8
Introduced
In Committee
Reported
Passed House
Passed Senate
Conference
To President
Became Law
WHAT THE BILL DOES
AI-written
Voters should care about this bill because it aims to directly reduce out-of-pocket prescription drug costs for many seniors. If passed, it means that when you pay a percentage of a drug's cost, that percentage will be calculated from the true, lower price the insurer paid, rather than a potentially higher, less transparent list price. This could lead to meaningful savings for individuals, making essential medications more affordable.
If it doesn't pass, seniors will continue to pay coinsurance based on the wholesale acquisition cost, potentially paying more than necessary for their medications, even when insurers receive significant discounts behind the scenes.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Changes how coinsurance for certain Medicare Part D drugs is calculated, basing it on the "actual acquisition cost" instead of the "wholesale acquisition cost" when the former is lower.
This could significantly reduce out-of-pocket costs for seniors by using the real, discounted price of drugs for calculating their share.
PROVISION 02
Defines "actual acquisition cost" as the negotiated price of a drug, minus any discounts or rebates from the manufacturer.
This ensures that the lower, net price paid by the plan is used for coinsurance calculation, reflecting the true cost.
PROVISION 03
The change in coinsurance calculation will apply to plan years beginning on or after January 1, 2026.
This sets a clear timeline for when seniors can expect to see potential savings.
PROVISION 04
The new calculation applies to costs above the annual deductible and below the annual out-of-pocket threshold, for drugs subject to coinsurance.
This clarifies the specific phase of Medicare Part D coverage where the lower coinsurance would apply, impacting a wide range of beneficiaries.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Voters should care about this bill because it aims to directly reduce out-of-pocket prescription drug costs for many seniors. If passed, it means that when you pay a percentage of a drug's cost, that percentage will be calculated from the true, lower price the insurer paid, rather than a potentially higher, less transparent list price. This could lead to meaningful savings for individuals, making essential medications more affordable.
If it doesn't pass, seniors will continue to pay coinsurance based on the wholesale acquisition cost, potentially paying more than necessary for their medications, even when insurers receive significant discounts behind the scenes.
KEY PROVISIONS
AI-extracted
high
Changes how coinsurance for certain Medicare Part D drugs is calculated, basing it on the "actual acquisition cost" instead of the "wholesale acquisition cost" when the former is lower.
This could significantly reduce out-of-pocket costs for seniors by using the real, discounted price of drugs for calculating their share.
high
Defines "actual acquisition cost" as the negotiated price of a drug, minus any discounts or rebates from the manufacturer.
This ensures that the lower, net price paid by the plan is used for coinsurance calculation, reflecting the true cost.
med
The change in coinsurance calculation will apply to plan years beginning on or after January 1, 2026.
This sets a clear timeline for when seniors can expect to see potential savings.
med
The new calculation applies to costs above the annual deductible and below the annual out-of-pocket threshold, for drugs subject to coinsurance.
This clarifies the specific phase of Medicare Part D coverage where the lower coinsurance would apply, impacting a wide range of beneficiaries.
Requirement that coinsurance for covered Part D drugs be based on actual acquisition cost begins for plan years.
GLOSSARY
AI-written
Medicare Part D
A government program that helps people on Medicare pay for prescription drugs.
Coinsurance
The percentage of a medical cost you are responsible for paying after your deductible, with your insurance paying the rest.
Wholesale Acquisition Cost (WAC)
A drug manufacturer's list price for a drug, typically before any discounts or rebates are applied, that wholesalers pay. It's often higher than what pharmacies or insurance plans actually pay.
Actual Acquisition Cost (AAC)
The real, net price that a pharmacy or insurance plan pays for a drug after accounting for all negotiated discounts and rebates from the manufacturer.
Deductible
The amount of money you must pay out of your own pocket for healthcare costs before your insurance plan starts to pay.
Out-of-Pocket Threshold
The maximum amount of money you have to pay for covered medical expenses in a year. Once you reach this limit, your insurance plan pays 100% of your covered costs.
Formulary
A list of prescription drugs covered by a health insurance plan.
ACTION TIMELINE
2 EVENTS
FEB 12, 25
Introduced in House
INTROREFERRAL
FEB 12, 25
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.